LIMITED STAGE SMALL CELL LUNG CANCER
Clinical trials for LIMITED STAGE SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LIMITED STAGE SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LIMITED STAGE SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to keep lung cancer at bay longer
Disease control Not yet recruitingThis study tests whether adding tarlatamab to durvalumab after standard chemotherapy and radiation can delay cancer return and extend life in people with limited-stage small cell lung cancer. Tarlatamab works by helping immune cells recognize and attack cancer cells. About 430 pa…
Matched conditions: LIMITED STAGE SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug combo aims to fight tough lung cancer
Disease control Not yet recruitingThis phase 2 trial is testing whether adding the immunotherapy drug adebrelimab to standard chemoradiotherapy can help people with limited-stage small-cell lung cancer. About 30 participants will receive the combination, followed by maintenance adebrelimab for up to 2 years. The …
Matched conditions: LIMITED STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC